BLCO | tickerfilter.com

Fundamental analysis

32%

Profitability 10%

Dept financing 24%

Liquidity 8%

Performance 61%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-4.47%

1 Month

-7.43%

3 Months

-18.11%

6 Months

-14.66%

1 Year

-4.28%

2 Year

-3.92%

Key data

Stock price

$15.19

P/E Ratio

0.00

DAY RANGE

$15.07 - $15.32

EPS

-$1.05

52 WEEK RANGE

$13.16 - $21.69

52 WEEK CHANGE

-$4.76

MARKET CAP

6.360 B

YIELD

N/A

SHARES OUTSTANDING

352.027 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.54

PUBLIC FLOAT

AVERAGE 10 VOLUME

$543,465

AVERAGE 30 VOLUME

$631,094

Company detail

CEO: Joseph C. Papa
Region: US
Website: bausch.com
Employees: 12,500
IPO year: 2022

Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Ophthalmic Goods
Sector: Manufacturing

Bausch + Lomb is a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions of people around the world—from the moment of birth through every phase of life.Our business was founded in 1853 and incorporated in the State of New York in 1908 (“Old Bausch + Lomb”). Our executive offices are located at 520 Applewood Crescent, Vaughan, Ontario, Canada.

BLCO - Bausch + Lomb Corp